0000899243-19-013799.txt : 20190516
0000899243-19-013799.hdr.sgml : 20190516
20190516173855
ACCESSION NUMBER: 0000899243-19-013799
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190514
FILED AS OF DATE: 20190516
DATE AS OF CHANGE: 20190516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hawkins Richard J
CENTRAL INDEX KEY: 0001307632
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32157
FILM NUMBER: 19833516
MAIL ADDRESS:
STREET 1: 950 TOWER LANE, SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Savara Inc
CENTRAL INDEX KEY: 0001160308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841318182
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY
STREET 2: SUITE 150
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 512-614-1848
MAIL ADDRESS:
STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY
STREET 2: SUITE 150
CITY: AUSTIN
STATE: TX
ZIP: 78746
FORMER COMPANY:
FORMER CONFORMED NAME: Mast Therapeutics, Inc.
DATE OF NAME CHANGE: 20130312
FORMER COMPANY:
FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030613
FORMER COMPANY:
FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010928
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-14
0
0001160308
Savara Inc
SVRA
0001307632
Hawkins Richard J
6836 BEE CAVE ROAD, BUILDING III
SUITE 200
AUSTIN
TX
78746
1
0
0
0
Common Stock
2019-05-14
4
M
0
21682
0.52
A
21682
D
Common Stock
2019-05-14
4
M
0
586
0.52
A
22268
D
Common Stock
2019-05-14
4
M
0
2288
0.52
A
24556
D
Common Stock
2019-05-14
4
M
0
444
0.55
A
25000
D
Common Stock
2019-05-14
4
S
0
14591
11.0654
D
10409
D
Common Stock
2019-05-15
4
S
0
10409
11.1602
D
0
D
Stock Option (Right to Buy)
0.52
2019-05-14
4
M
0
21682
0.00
D
2020-10-22
Common Stock
21682
0
D
Stock Option (Right to Buy)
0.52
2019-05-14
4
M
0
586
0.00
D
2020-12-17
Common Stock
586
0
D
Stock Option (Right to Buy)
0.52
2019-05-14
4
M
0
2288
0.00
D
2021-08-30
Common Stock
2288
0
D
Stock Option (Right to Buy)
0.55
2019-05-14
4
M
0
444
0.00
D
2021-12-16
Common Stock
444
728
D
The price is a weighted average sale price. The sale prices ranged from $10.97 to $11.16. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price is a weighted average sale price. The sale prices ranged from $10.99 to $11.31. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
5,420 of the shares subject to the option vested and became exercisable on October 22, 2010, and the remaining shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on January 22, 2011.
The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 17, 2011.
The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on November 18, 2011.
The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 16, 2012.
/s/ David Lowrance as attorney-in-fact for Richard J. Hawkins
2019-05-16